Since the literature described "gif uct180", olympus selected "gf-uct180" as a representative product.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
|
Olympus reviewed the following literature titled "eus-guided biliary drainage in patients with moderate¿severe cholangitis is safe and effective: a multi-center experience." this is a retrospective review of a prospectively maintained endoscopy database to assess outcomes of endoscopic ultrasound-guided biliary drainage (eus-bd) in patients with moderate¿severe cholangitis.A total of 263 cases of eus-bd were reviewed.Of the 49 patients (23 male; 46.9%) presenting with moderate/severe cholangitis, 23 (46.9%) had severe cholangitis.Clinical success with improvement of cholangitis, on the overall cohort, was 91.7% (44/48).Effective biliary drainage (ebd) defined as reduction in bilirubin by more than 50% of baseline at 2 weeks, and/or bilirubin<3.0 mg/dl at 4 weeks.Ebd, on the overall cohort, was noted in 85.4% (41/48) cases.Adverse events in the form of mostly bleeding and bile leak were noted in 5 cases (10.2%) but managed conservatively.Distal obstruction exhibited significantly better clinical success (100% vs.78.9%; p=0.02) than hilar obstruction.In conclusion, in case of failed/non-feasible ercp, eus-bd can be a safe and an effective alternative option for patients with moderate to severe cholangitis, even with significant pre-morbid conditions, with acceptable adverse events rate.Type of adverse events/number of patients: bleeding : 1 patient.Intrahepatic cholestasis : 1 patient.Hemobilia : 2 patients.Bile leak :1 patient.Death 2 days after procedure due to massive pulmonary embolism : 1 patient.Death 3 months after procedure : 10 patient.This literature article requires 2 reports.The related patient identifiers are as follows: (b)(6): for adverse events.(b)(6): for patient death.This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
|